These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 3278174

  • 1. Cyclosporine nephrotoxicity is minimized by adjusting dosage on the basis of drug concentration in blood.
    Moyer TP, Post GR, Sterioff S, Anderson CF.
    Mayo Clin Proc; 1988 Mar; 63(3):241-7. PubMed ID: 3278174
    [Abstract] [Full Text] [Related]

  • 2. Two immunosuppressive drug regimens after renal transplantation: low dosage of cyclosporine adjusted on the basis of high-performance liquid chromatography whole blood levels and prednisone.
    Uchida K, Orihara A, Yamada N, Tominaga Y, Kawai M, Tanaka Y, Morozumi K, Hayashi S, Satake M, Taira N.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):401-5. PubMed ID: 3279629
    [No Abstract] [Full Text] [Related]

  • 3. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL, Hodgson RJ, Merion RM, Swartz RD, Keavey S, Turcotte JG, Campbell DA.
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI, Flechner SM, Van Buren CT, Kerman RH, Kahan BD.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract] [Full Text] [Related]

  • 5. Management of cyclosporine toxicity by reduced dosage and azathioprine.
    Griffith BP, Hardesty RL, Lee A, Trento A, Thompson ME, Shapiro AP, Bahnson HT.
    J Heart Transplant; 1985 Aug; 4(4):410-3. PubMed ID: 3916516
    [Abstract] [Full Text] [Related]

  • 6. Beneficial effects of cyclosporine compared with azathioprine in cadaveric renal transplantation.
    Henry ML, Sommer BG, Ferguson RM.
    Am J Surg; 1985 Nov; 150(5):533-6. PubMed ID: 2998215
    [Abstract] [Full Text] [Related]

  • 7. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS, Samhan M, John P, al-Adnani MS, Abouna GM.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract] [Full Text] [Related]

  • 8. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
    Landsberg DN, Rae A, Chiu A, Werb R, Taylor P, Chan-Yan C, Manson AD.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safe conversion from cyclosporine to azathioprine with improved renal function in pediatric renal transplantation.
    Kaiser BA, Lawless ST, Palmer JM, Dunn SP, Polinsky MS, Baluarte HJ.
    Pediatr Nephrol; 1989 Oct; 3(4):401-5. PubMed ID: 2642107
    [Abstract] [Full Text] [Related]

  • 11. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL, Canafax DM, Strand M, Ascher NL, Payne WD, Sutherland DE, Najarian JS.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract] [Full Text] [Related]

  • 12. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM, Lorber M, Van Buren C, Kerman R, Kahan BD.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin.
    Cho SI, Bradley JW, Monaco AP, Tilney NL.
    Am J Surg; 1984 Apr; 147(4):518-23. PubMed ID: 6370008
    [Abstract] [Full Text] [Related]

  • 14. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR, Morris PJ.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract] [Full Text] [Related]

  • 15. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility.
    Shaw LM, Audet PR, Grossman RA, Fields L, Lensmeyer GL, Dafoe DC.
    Transplant Proc; 1990 Jun; 22(3):1267-73. PubMed ID: 2349688
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
    Porayko MK, Textor SC, Krom RA, Hay JE, Gores GJ, Richards TM, Crotty PH, Beaver SJ, Steers JL, Wiesner RH.
    Mayo Clin Proc; 1994 Feb; 69(2):105-11. PubMed ID: 7508536
    [Abstract] [Full Text] [Related]

  • 18. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G, Mihatsch M, Landmann J, Hermle M, Brunner FP, Harder F.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract] [Full Text] [Related]

  • 19. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
    Landsberg D, Rae A, Chiu A, Werb R, Taylor P, Chan-Yan C, Manson AD.
    Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
    [No Abstract] [Full Text] [Related]

  • 20. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.
    Lindholm A, Dahlqvist R, Groth GG, Sjöqvist F.
    Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.